Kamakura, Japan

Yohei Miyamoto

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Toray Industries, Inc.. Active years: 2013.

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yohei Miyamoto: Innovator in Alzheimer's Disease Treatment

Introduction

Yohei Miyamoto is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of medicine, particularly in the development of therapeutic agents for Alzheimer's disease. His innovative work aims to provide effective solutions for a condition that affects millions worldwide.

Latest Patents

Miyamoto holds a patent for a therapeutic agent and preventative agent for Alzheimer's disease. This invention is designed to inhibit or delay the progression of Alzheimer's disease and demonstrates a long-lasting therapeutic effect even with prolonged use. The agent includes a cyclohexane derivative or a pharmaceutically acceptable salt or prodrug thereof, showcasing his commitment to advancing medical treatments.

Career Highlights

Miyamoto is associated with Toray Industries, Inc., where he continues to work on groundbreaking research and development projects. His dedication to innovation in healthcare has positioned him as a key figure in the fight against Alzheimer's disease.

Collaborations

Some of his notable coworkers include Kaoru Nakao and Naohiro Yamada. Their collaborative efforts contribute to the advancement of research and the development of effective treatments.

Conclusion

Yohei Miyamoto's work in developing therapeutic agents for Alzheimer's disease highlights his innovative spirit and commitment to improving healthcare. His contributions are vital in the ongoing battle against this challenging condition.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…